Silver Cross Pharmaceuticals Llp - Company overview

Silver Cross Pharmaceuticals LLP was incorporated on 10 December 2013 and is registered with ROC Bangalore.

2013-12-10 Bangalore, Karnataka Active LLP
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹5–10 Cr
▼ -40.9%
FY 2023
PROFIT / LOSS
Loss · ₹1–5 Cr
▼ -10048.0%
FY 2023
EBITDA
₹1–5 Cr
▲ 152.9%
FY 2023
NET WORTH
-
FY 2023
TOTAL ASSETS
₹10–25 Cr
▼ -2.0%
FY 2023
OPEN CHARGES
-
-
PAID-UP CAPITAL
-
AUTHORISED CAPITAL
1.00 Lakh
COMPANY AGE
12 Years 10 Months
since 2013-12-10
LAST FILING WITH ROC
2023-03-31
Last AGM: 2023-03-31
ACTIVE GST
-
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Silver Cross Pharmaceuticals Llp covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
59/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (75), financial health (30), director (50) and company-foundation signals.
  • Operating for 12+ years.
Compliance Score Low risk
75/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2023 - filings look overdue.
Financial Health Score High risk
30/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2023.
  • Revenue fell 40.9% year-on-year.
Director Risk Score Moderate
50/100
Board strength, DIN status and churn.
  • 2 directors on the board.
  • Director AKASH UTTAM JAIN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Silver Cross Pharmaceuticals Llp Company identity, industry, contact, and registration details from MCA and company records.

Silver Cross Pharmaceuticals LLP was incorporated on 10 December 2013 and is registered with ROC Bangalore. It is an active limited liability partnership, now about 12 years old. Its registered office is at No.6, 3Rd Main Road, Ramamohanapura, Gayatri Nagar, Bangalore, Karnataka.

Infyner groups it under Pharma, in the Drug Formulation & Development segment.

Its two current partners - Akash Uttam Jain and Uttam Kumar Pukharaj Jain - were all appointed on 1 April 2022. Two former partners are on record; the most recent to leave was Vishal Subhas Chand Pipada in May 2015. Between them, the partners also sit on the boards of 3 other companies, including Front Source Technologies Private Limited and Mahaveer Medicaid Private Limited.

The last annual filing on record was on 31 March 2023, for accounts made up to 31 March 2023. Nothing newer than 2023 shows up here, so it is worth checking the MCA portal for later filings. No charges (secured loans) are registered against it.

Pharma ••••••••
  • Location No.6, 3Rd Main Road, Ramamohanapura, Gayatri Nagar, Bangalore, Karnataka - 560021
Legal NameSilver Cross Pharmaceuticals Llp
CIN / LLPINAAB-9190
Company No.-
ClassificationLimited Liability Partnership
Incorporation Date2013-12-10
Date of AGM2023-03-31
Date of Balance Sheet2023-03-31
Listing Status-
ROC CodeRoc Bangalore
PAN
LEI Number
Active Compliance-

Current Partners of Silver Cross Pharmaceuticals Llp (2) Current board members from MCA filings, including designation and appointment details.

A
Akash Uttam Jain
Designated Partner | Since 2022-04-01 | DIN: 07272587
U
Uttam Kumar Pukharaj Jain
Designated Partner | Since 2022-04-01 | DIN: 08066448

Financial Performance of Silver Cross Pharmaceuticals Llp Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹5–10 Cr ▼ -40.9%
P&L Loss · ₹1–5 Cr ▼ -10048.0%
EBITDA ₹1–5 Cr ▲ 152.9%
Net worth -

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Companies With Common Directors Of Silver Cross Pharmaceuticals Llp Other companies that share directors with this entity, based on MCA and compliance network data.

Board Overlap From MCA / Compliance Filings

Front Source Technologies Private Limited 1 Shared Director
Mahaveer Medicaid Private Limited 1 Shared Director
Palaver Technology Private Limited 1 Shared Director

Financial Ratios of Silver Cross Pharmaceuticals Llp Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

8 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

LLP Contribution of Silver Cross Pharmaceuticals Llp Ownership and contribution detail from filings. Full breakdown unlocks with your report.

6 contribution years on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Silver Cross Pharmaceuticals Llp MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Silver Cross Pharmaceuticals Llp Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Silver Cross Pharmaceuticals Llp Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Silver Cross Pharmaceuticals LLP?
In an LLP the partners are the owners. The partners on record for Silver Cross Pharmaceuticals LLP are Akash Uttam Jain and Uttam Kumar Pukharaj Jain.
Who are the current designated partners and partners of Silver Cross Pharmaceuticals LLP?
Silver Cross Pharmaceuticals LLP has two partners on record: Akash Uttam Jain (since April 2022) and Uttam Kumar Pukharaj Jain (since April 2022).
What is LLPIN/FCRN number of Silver Cross Pharmaceuticals LLP?
The LLPIN of Silver Cross Pharmaceuticals LLP is AAB-9190. Unlike a company CIN, an LLPIN is a short serial number and does not encode the state or year.
When was Silver Cross Pharmaceuticals LLP incorporated?
Silver Cross Pharmaceuticals LLP was incorporated on 10 December 2013 with ROC Bangalore. That makes it about 12 years old.
What is the registered address of Silver Cross Pharmaceuticals LLP?
The registered office on MCA records is No.6, 3Rd Main Road, Ramamohanapura, Gayatri Nagar, Bangalore, Karnataka - 560021.
What is the current status of Silver Cross Pharmaceuticals LLP?
MCA shows Silver Cross Pharmaceuticals LLP as Active, and its last annual filing on record was in March 2023.
What is the contact number or email for Silver Cross Pharmaceuticals LLP?
You can post to its registered office at No.6, 3Rd Main Road, Ramamohanapura, Gayatri Nagar, Bangalore, Karnataka - 560021.
What industry or business activity is Silver Cross Pharmaceuticals LLP associated with?
It is grouped under Pharma, in the Drug Formulation & Development segment.
When did Silver Cross Pharmaceuticals LLP last file its annual return and accounts?
The last annual filing on record was on 31 March 2023, and the latest balance sheet is for the year ending 31 March 2023. Nothing newer than 2023 shows up, so check the MCA portal for later filings.
Where can I see charges and lenders for Silver Cross Pharmaceuticals LLP?
MCA shows no charges registered against Silver Cross Pharmaceuticals LLP, so no assets are pledged for a registered secured loan.
Have any partners left Silver Cross Pharmaceuticals LLP?
Yes, two former partners are on record. Vishal Subhas Chand Pipada (May 2015) left.
Which companies share directors with Silver Cross Pharmaceuticals LLP?
3 companies share partners with Silver Cross Pharmaceuticals LLP: Front Source Technologies Private Limited, Mahaveer Medicaid Private Limited and Palaver Technology Private Limited.
What is the turnover or revenue of Silver Cross Pharmaceuticals LLP?
Based on filed financial statements, the revenue of Silver Cross Pharmaceuticals LLP for FY 2023 was in the ₹5–10 Cr range. That is down 40.9% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
How can I get the financial details of Silver Cross Pharmaceuticals LLP?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the ROC code of Silver Cross Pharmaceuticals LLP?
Silver Cross Pharmaceuticals LLP is registered with ROC Bangalore.
What is the company classification of Silver Cross Pharmaceuticals LLP?
MCA classifies Silver Cross Pharmaceuticals LLP as: Limited Liability Partnership.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.